School Of Medicine

At the beginning of 2022, the School of Medicine launched a $5 million Dean’s Scholarship Challenge to help ensure that tomorrow’s leaders in medicine are educated at Vanderbilt. The success of the early months of the effort has prompted the university to boost the available matching funds by $5 million. Read More

Class of 2022: Growing up, Dillon Pruett didn’t know anyone who stuttered like he did, but he was well aware of how widely misunderstood the disorder was, both among children and adults. As he learned more about the science behind it, he became determined to dispel those misconceptions. Today the Basic Sciences Ph.D. candidate is conducting novel genetic research to provide a better understanding of stuttering and ultimately develop new therapies to treat it. Read More

Vanderbilt University’s graduate programs showed continued strength in the 2023 "U.S. News & World Report" Best Graduate Schools rankings, with five of Vanderbilt’s graduate and professional schools falling within the top 25. Read More

A team including the Sanders lab developed a new methodology for finding small molecules associated with lipid rafts, an essential part of cell structure and regulation. Read More

Body-made cannabinoids that fine tune hunger signals in the brain have been mapped, with implications for helping those with deadly feeding-related illnesses Read More

Ege Kavalali and Heidi Hamm collaborated to discover a signaling pathway for how spontaneous release of neurotransmitters can be selectively regulated without disrupting evoked action potentials. Read More

As head of the Metro Nashville Coronavirus Task Force, Jahangir has helped coordinate local health systems and community groups, addressed the city at daily media briefings, set up COVID test sites and advised policymakers on combatting the virus, all while maintaining his normal duties at Vanderbilt. Read More

Patricia Gail “Trish” Champion Frist, BA’61, of Nashville, who had a great impact as a philanthropist and business advocate, died Jan. 5. Read More

Unique somatic gene mutations may contribute to racial disparities in the incidence of Wilms tumor — the most common childhood kidney cancer. Read More

The remarkable success of the COVID-19 vaccines began in a Vanderbilt lab decades ago, with the groundbreaking research of alumnus Dr. Barney Graham. Read More

Vanderbilt University Senior Associate Dean for Health Sciences Education and Professor of Medicine Donald W. Brady discusses the importance of continuing to follow COVID-19 health and safety protocols even after receiving the vaccine during the Spring Return to Campus Town Hall on Jan. 13, 2021. Read More

(Anne Rayner/Vanderbilt) Nashville Business Journal recently released its 2021 “40 under 40” list of honorees, featuring six Vanderbilt alumni and two faculty members: Maya Bugg, EdD’18, president and CEO, Tennessee Charter School Center Christiane Buggs, MEd’14, board chair, The Metropolitan Nashville Board of Public Education and founding board member… Read More

A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center. Read More

Vanderbilt University Medical Center (VUMC) researchers are enrolling adults aged 75 and over to study whether taking atorvastatin, a drug commonly used to lower cholesterol also called Lipitor®, can help maintain health by preventing dementia, disability, and heart disease. Read More

Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19. Read More

Consuelo Hopkins Wilkins, professor of medicine in the School of Medicine and vice president for health equity at Vanderbilt University Medical Center, has received one of the highest honors in health and medicine. Read More

A new study from Vanderbilt epidemiologists suggests that it’s time to reconsider clinical practice guidelines for the treatment of early-stage breast cancer in older women. Read More

A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions. Read More

Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes. Read More

Angelika Amon, PhD, a pioneering cell and molecular biologist and winner of the 2018 Vanderbilt Prize in Biomedical Science, died Oct. 29 from cancer. She was 53. Read More